BIO 101
Alternative Names: BIO-101 - Reyon Pharmaceuticals; RY 101Latest Information Update: 02 Aug 2023
At a glance
- Originator Reyon Pharmaceutical
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatitis B
Most Recent Events
- 17 Jul 2023 Preclinical trials in Hepatitis B in South Korea (Parenteral), prior to July 2023 (Reyon Pharmaceuticals, July 2023)